Cannabis Flowers For Treating Chronic Pain Now Available In New Zealand As Tea

Comments
Loading...

New Zealand's first "legal weed" has arrived in pharmacies in the form of tea via an agreement with the pharmaceutical company Australian Natural Therapeutics Group (ANTG), reported local media.

The firm received approval from the Ministry of Health to sell its products to patients with chronic pain and a prescription.

In February, the Ministry of Health of New Zealand issued guidance on two new medicinal cannabis products that have been verified as meeting the minimum quality standard. Authorized products now include ANTG’s “Mariposa,” “Eve” and “Rocky,” tea preparations for oral consumption.

ANTG’s stated it is the first company able to legally sell dried flowers in New Zealand, which will be accessed through New Zealand’s NUBU Pharmaceuticals.

“ANTG entered into a partnership agreement with NUBU Pharmaceuticals in May last year,” reported Hemp Gazzette.

“It’s a historic moment in medicine for both countries, with our verifications meaning New Zealand patients can finally visit their GP to request alternatives for conditions such as chronic pain and many more,” said ANTG CEO Matt Cantelo.

"This is a great day for New Zealand, just across the Tasman they've had dried flowers available to be prescribed by doctors for at least two to three years - we've been waiting a long time for this," said Mark Hotu, co-founder of Green Doctors, a Medicinal Cannabis clinic.

Photo by David Peterson via Pixabay. 

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.